Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10849261rdf:typepubmed:Citationlld:pubmed
pubmed-article:10849261lifeskim:mentionsumls-concept:C0369335lld:lifeskim
pubmed-article:10849261lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10849261lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:10849261lifeskim:mentionsumls-concept:C0524910lld:lifeskim
pubmed-article:10849261lifeskim:mentionsumls-concept:C0017431lld:lifeskim
pubmed-article:10849261lifeskim:mentionsumls-concept:C0041703lld:lifeskim
pubmed-article:10849261pubmed:issue3lld:pubmed
pubmed-article:10849261pubmed:dateCreated2000-7-28lld:pubmed
pubmed-article:10849261pubmed:abstractTextHepatitis C virus (HCV) RNA status and HCV genotype have become important tools in the diagnosis and monitoring of therapy in chronic HCV infection. To establish a database with respect to HCV genotype and serum HCV RNA concentrations in chronic hepatitis C patients in the United States, we analysed 6807 chronic hepatitis C patients who had HCV RNA and HCV genotype tests conducted at a central laboratory. The HCV RNA concentration cut-off for the lower 25th percentile of this population (low titre) was 0.9 x 106 copies ml-1. The median HCV RNA concentration was 3.5 x 106 copies ml-1 and the cut-off for the upper 25th percentile (high titre) was 5 x 106 copies ml-1. Male patients had a median HCV RNA concentration of 3.9 x 106 copies ml-1, which was significantly higher than the median HCV RNA level for females (2.75 x 106 copies ml-1; P < 0.001). HCV genotype 1 was detected in 73% of patients; genotype 2 in 14%; genotype 3 in 8%; mixed genotype in 4%; and genotypes 4, 5 and 6 with a frequency of < 1%. Patients from the Northeast, Southeast and Midwest had significantly (P < 0.001) more infections with genotype 1 than patients from the Western and Southern regions. African-American patients were more likely to be infected with genotype 1 when compared with Caucasian, Hispanic or Asian Pacific Islanders (P < 0.001). Patients infected with HCV genotype 1 and mixed HCV genotypes had significantly higher serum HCV RNA concentrations when compared with HCV genotypes 2 and 3 (P < 0.001 for all comparisons).lld:pubmed
pubmed-article:10849261pubmed:languageenglld:pubmed
pubmed-article:10849261pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10849261pubmed:citationSubsetIMlld:pubmed
pubmed-article:10849261pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10849261pubmed:statusMEDLINElld:pubmed
pubmed-article:10849261pubmed:monthMaylld:pubmed
pubmed-article:10849261pubmed:issn1352-0504lld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:SchmidPPlld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:TongM JMJlld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:SmithCClld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:HerreraJJlld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:ConradAAlld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:BadaVVlld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:MutchnickM...lld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:TobiasHHlld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:McHutchisonJ...lld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:BlattL MLMlld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:LebovicsEElld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:KlionF MFMlld:pubmed
pubmed-article:10849261pubmed:authorpubmed-author:FreilichBBlld:pubmed
pubmed-article:10849261pubmed:issnTypePrintlld:pubmed
pubmed-article:10849261pubmed:volume7lld:pubmed
pubmed-article:10849261pubmed:ownerNLMlld:pubmed
pubmed-article:10849261pubmed:authorsCompleteYlld:pubmed
pubmed-article:10849261pubmed:pagination196-202lld:pubmed
pubmed-article:10849261pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:meshHeadingpubmed-meshheading:10849261...lld:pubmed
pubmed-article:10849261pubmed:year2000lld:pubmed
pubmed-article:10849261pubmed:articleTitleAssessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States.lld:pubmed
pubmed-article:10849261pubmed:affiliationNational Genetics Institute, Los Angeles, CA, USA.lld:pubmed
pubmed-article:10849261pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10849261pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10849261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10849261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10849261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10849261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10849261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10849261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10849261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10849261lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10849261lld:pubmed